These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17034359)

  • 1. Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation?
    Haghdoost S; Maruyama Y; Pecoits-Filho R; Heimburger O; Seeberger A; Anderstam B; Suliman ME; Czene S; Lindholm B; Stenvinkel P; Harms-Ringdahl M
    Antioxid Redox Signal; 2006; 8(11-12):2169-73. PubMed ID: 17034359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
    Avci E; Cakir E; Cevher SC; Yaman H; Agilli M; Bilgi C
    Ren Fail; 2014 Jun; 36(5):767-73. PubMed ID: 24579657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
    Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo and in vitro.
    Haghdoost S; Czene S; Näslund I; Skog S; Harms-Ringdahl M
    Free Radic Res; 2005 Feb; 39(2):153-62. PubMed ID: 15763963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
    Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
    Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
    Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients.
    El-Shehaby AM; El-Khatib MM; Battah AA; Roshdy AR
    Scand J Clin Lab Invest; 2010 Oct; 70(6):421-7. PubMed ID: 20645679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.
    McIntyre C; Harper I; Macdougall IC; Raine AE; Williams A; Baker LR
    Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
    Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
    Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between periodontitis and systemic inflammation in patients with end-stage renal disease.
    Nadeem M; Stephen L; Schubert C; Davids MR
    SADJ; 2009 Nov; 64(10):470-3. PubMed ID: 20306866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nucleotide pool, a target for low-dose gamma-ray-induced oxidative stress.
    Sangsuwan T; Haghdoost S
    Radiat Res; 2008 Dec; 170(6):776-83. PubMed ID: 19138035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease.
    Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
    Atherosclerosis; 2009 May; 204(1):309-14. PubMed ID: 18823890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage.
    Kaya Y; Ari E; Demir H; Soylemez N; Cebi A; Alp H; Bakan E; Gecit I; Asicioglu E; Beytur A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1164-9. PubMed ID: 21821836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nucleotide pool is a significant target for oxidative stress.
    Haghdoost S; Sjölander L; Czene S; Harms-Ringdahl M
    Free Radic Biol Med; 2006 Aug; 41(4):620-6. PubMed ID: 16863995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease.
    Kalender B; Ozdemir AC; Koroglu G
    Nephron Clin Pract; 2006; 102(3-4):c115-21. PubMed ID: 16282695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension.
    Espinosa O; Jiménez-Almazán J; Chaves FJ; Tormos MC; Clapes S; Iradi A; Salvador A; Fandos M; Redón J; Sáez GT
    Free Radic Res; 2007 May; 41(5):546-54. PubMed ID: 17454137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of oxidative stress in advanced kidney disease].
    Puchades Montesa MJ; González Rico MA; Solís Salguero MA; Torregrosa Maicas I; Tormos Muñoz MC; Saez Tormo G; Juan Garcia I; Miguel Carrasco A
    Nefrologia; 2009; 29(5):464-73. PubMed ID: 19820759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants.
    Fanti P; Asmis R; Stephenson TJ; Sawaya BP; Franke AA
    Nephrol Dial Transplant; 2006 Aug; 21(8):2239-46. PubMed ID: 16766544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.